Oncorus Stock Cash Flow From Operations
ONCRDelisted Stock | USD 0.04 0.01 14.71% |
Oncorus fundamentals help investors to digest information that contributes to Oncorus' financial success or failures. It also enables traders to predict the movement of Oncorus Stock. The fundamental analysis module provides a way to measure Oncorus' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Oncorus stock.
Oncorus |
Oncorus Company Cash Flow From Operations Analysis
Oncorus' Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Oncorus Cash Flow From Operations | (61.69 M) |
Most of Oncorus' fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Oncorus is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
CompetitionIn accordance with the recently published financial statements, Oncorus has (61.69 Million) in Cash Flow From Operations. This is 111.7% lower than that of the Healthcare sector and 198.66% lower than that of the Biotechnology industry. The cash flow from operations for all United States stocks is 106.35% higher than that of the company.
Oncorus Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Oncorus' direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Oncorus could also be used in its relative valuation, which is a method of valuing Oncorus by comparing valuation metrics of similar companies.Oncorus is currently under evaluation in cash flow from operations category among its peers.
Oncorus Fundamentals
Return On Equity | -1.25 | |||
Return On Asset | -0.32 | |||
Current Valuation | 25.71 M | |||
Shares Outstanding | 26.09 M | |||
Shares Owned By Insiders | 12.69 % | |||
Shares Owned By Institutions | 55.29 % | |||
Number Of Shares Shorted | 447.72 K | |||
Price To Book | 0.13 X | |||
EBITDA | (75.42 M) | |||
Net Income | (77.42 M) | |||
Cash And Equivalents | 100.24 M | |||
Cash Per Share | 3.86 X | |||
Total Debt | 70.65 M | |||
Debt To Equity | 0.72 % | |||
Current Ratio | 6.42 X | |||
Book Value Per Share | 1.19 X | |||
Cash Flow From Operations | (61.69 M) | |||
Short Ratio | 0.74 X | |||
Earnings Per Share | (5.49) X | |||
Target Price | 5.0 | |||
Number Of Employees | 64 | |||
Beta | 2.85 | |||
Market Capitalization | 3.15 M | |||
Total Asset | 145.59 M | |||
Retained Earnings | (272.01 M) | |||
Working Capital | 27.41 M | |||
Z Score | -4.07 | |||
Net Asset | 145.59 M |
About Oncorus Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Oncorus's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oncorus using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oncorus based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Oncorus Stock
If you are still planning to invest in Oncorus check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oncorus' history and understand the potential risks before investing.
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Commodity Directory Find actively traded commodities issued by global exchanges |